Cardiac arrest and cardiopulmonary resuscitation dysregulates the hypothalamic-pituitary-adrenal axis.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 3815600)

Published in J Cereb Blood Flow Metab on June 24, 2009

Authors

Gretchen N Neigh1, Kate Karelina, Ning Zhang, Erica R Glasper, Michael J Owens, Paul M Plotsky, Charles B Nemeroff, A Courtney Devries

Author Affiliations

1: Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, Georgia 30322, USA. gretchen.neigh@emory.edu

Articles cited by this

Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med (2002) 21.40

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods (1985) 9.05

Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation (2008) 5.97

Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res (2002) 4.93

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev (1991) 2.85

Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation. N Engl J Med (2003) 2.68

Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation (2005) 1.88

Histopathological and behavioral characterization of a novel model of cardiac arrest and cardiopulmonary resuscitation in mice. J Neurosci Methods (2004) 1.45

Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacology (1999) 1.27

Life after survival: long-term daily functioning and quality of life after an out-of-hospital cardiac arrest. Resuscitation (2009) 1.24

Global cerebral ischemia due to cardiocirculatory arrest in mice causes neuronal degeneration and early induction of transcription factor genes in the hippocampus. Brain Res Mol Brain Res (1999) 1.08

Cortisol levels and adrenal reserve after successful cardiac arrest resuscitation. Shock (2004) 1.04

Cardiac arrest/cardiopulmonary resuscitation increases anxiety-like behavior and decreases social interaction. J Cereb Blood Flow Metab (2004) 1.02

Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems. J Neurosci (2000) 0.99

Quality of survival after cardiopulmonary resuscitation. Arch Intern Med (1999) 0.98

Pressor drugs in the treatment of cardiac arrest. Cardiol Clin (2002) 0.97

Quetiapine attenuates the depressive and anxiolytic-like behavioural changes induced by global cerebral ischemia in mice. Behav Brain Res (2007) 0.92

Pattern of neuronal loss in the rat hippocampus following experimental cardiac arrest-induced ischemia. J Neurol Sci (1999) 0.92

Life after cardiac arrest; a retrospective study. Resuscitation (1996) 0.91

Evaluation of a tape removal test to assess neurological deficit after cardiac arrest in rats. Resuscitation (2007) 0.91

Social isolation potentiates cell death and inflammatory responses after global ischemia. Mol Psychiatry (2008) 0.89

The cerebral 'no-reflow' phenomenon after cardiac arrest in rats--influence of low-flow reperfusion. Resuscitation (1997) 0.89

Subjective complaints versus neuropsychological test performance after cardiopulmonary bypass. J Psychosom Res (1995) 0.88

Long-acting psychotraumatic properties of a cardiac arrest experience. Am J Psychiatry (1999) 0.87

Cardiovascular function and neurologic outcome after cardiac arrest in dogs. The cardiovascular post-resuscitation syndrome. Resuscitation (1993) 0.87

Ischemia-induced anxiety following cardiac arrest in the rat. Behav Brain Res (1997) 0.87

Postoperative neuropsychological change and its underlying mechanism in patients undergoing coronary artery bypass grafting. Chin Med J (Engl) (2007) 0.86

Reduced cerebral injury in CRH-R1 deficient mice after focal ischemia: a potential link to microglia and atrocytes that express CRH-R1. J Cereb Blood Flow Metab (2003) 0.86

Time-dependent changes in CRH concentrations and release in discrete brain regions following global ischemia: effects of MK-801 pretreatment. Brain Res (2004) 0.84

Trajectories and predictors of anxiety and depression in women during the 12 months following an acute cardiac event. Br J Health Psychol (2008) 0.84

Characterization of anxiety and habituation profile following global ischemia in rats. Physiol Behav (2005) 0.81

Hypothalamic-pituitary-adrenocortical system and mood disorders: highlights from mutant mice. Neuroendocrinology (2004) 0.81

Focal cerebral ischemia induces CRH mRNA in rat cerebral cortex and amygdala. Neuroreport (1995) 0.80

Corticotropin-releasing factor: effect on cerebral blood flow in physiologic and ischaemic conditions. Exp Brain Res (2005) 0.80

Unrecognized organic mental disorders in survivors of cardiac arrest. Am J Psychiatry (1983) 0.79

Quality of life after cardiopulmonary resuscitation. Chest (1994) 0.78

Long-term cognitive and neuropsychological symptoms after global cerebral ischemia in Mongolian gerbils. Acta Neurochir Suppl (2006) 0.78

In vivo administration of corticotropin-releasing hormone at remote intervals following ischemia enhances CA1 neuronal survival and recovery of spatial memory impairments: a role for opioid receptors. Behav Brain Res (2007) 0.78

The CRH1 antagonist CP154,526 failed to alter ischemia-induced neurodegeneration and spatial memory deficits in rats but inhibited behavioral activity in the novel open field. Behav Brain Res (2005) 0.77

Does rat global transient cerebral ischemia serve as an appropriate model to study emotional disturbances? Fundam Clin Pharmacol (2004) 0.77

Corticotropin-releasing factor (CRF) can directly affect brain microvessel endothelial cells. Brain Res (2003) 0.77

Cardiac arrest/cardiopulmonary resuscitation augments cell-mediated immune function and transiently suppresses humoral immune function. J Cereb Blood Flow Metab (2005) 0.77

Focal cerebral ischaemia induces corticotropin releasing factor (CRF) vascular immunoreactivity in rat occluded hemisphere. Regul Pept (2007) 0.77

Articles by these authors

A uniform proteomics MS/MS analysis platform utilizing open XML file formats. Mol Syst Biol (2005) 9.81

A higher-level phylogenetic classification of the Fungi. Mycol Res (2007) 7.93

Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA (2008) 6.60

The amsterdam declaration on fungal nomenclature. IMA Fungus (2011) 5.86

Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81

Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci (2012) 4.71

Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry (2008) 4.65

The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry (2007) 4.51

The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry (2005) 4.45

The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology (2008) 4.35

PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65. Open Biol (2012) 3.42

Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry (2006) 3.33

Are mood disorders and obesity related? A review for the mental health professional. J Clin Psychiatry (2004) 3.26

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology (2002) 3.24

Treatment of mood disorders. Nat Neurosci (2002) 3.13

Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry (2002) 3.05

Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood (2010) 3.03

Early life programming and neurodevelopmental disorders. Biol Psychiatry (2010) 2.93

Development and natural history of mood disorders. Biol Psychiatry (2002) 2.90

Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C. Brain Behav Immun (2005) 2.52

Long-term consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat offspring. Neuropsychopharmacology (2005) 2.35

Reduced glucocorticoid receptors: consequence or cause of depression? Trends Endocrinol Metab (2006) 2.26

Neurobiological and psychiatric consequences of child abuse and neglect. Dev Psychobiol (2010) 2.17

Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J Clin Microbiol (2008) 2.16

Depression, desperation, and suicidal ideation in college students: results from the American Foundation for Suicide Prevention College Screening Project at Emory University. Depress Anxiety (2008) 2.16

Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry (2003) 2.13

Social modulation of stress responses. Physiol Behav (2003) 2.11

Environmental enrichment reverses the effects of maternal separation on stress reactivity. J Neurosci (2002) 2.10

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry (2003) 2.05

Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J Exp Med (2008) 2.04

Importance of studying the contributions of early adverse experience to neurobiological findings in depression. Neuropsychopharmacology (2004) 2.03

Reduced mitochondrial DNA copy number is correlated with tumor progression and prognosis in Chinese breast cancer patients. IUBMB Life (2007) 1.92

Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am J Psychiatry (2003) 1.90

Trastuzumab-related cardiotoxicity among older patients with breast cancer. J Clin Oncol (2013) 1.89

Clinical and MRI characteristics of levamisole-induced leukoencephalopathy in 16 patients. J Neuroimaging (2009) 1.84

Protein cross-linking analysis using mass spectrometry, isotope-coded cross-linkers, and integrated computational data processing. J Proteome Res (2006) 1.81

Anterior cingulate activation and error processing during interferon-alpha treatment. Biol Psychiatry (2005) 1.80

Long-term behavioural and molecular alterations associated with maternal separation in rats. Eur J Neurosci (2007) 1.79

International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmacol Rev (2003) 1.79

The relationship of depression and diabetes: pathophysiological and treatment implications. Psychoneuroendocrinology (2011) 1.74

The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis. Depress Anxiety (2002) 1.72

The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma. Biol Psychiatry (2007) 1.71

Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer. Cancer Res (2004) 1.70

The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet (2005) 1.70

Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors. Sci Transl Med (2012) 1.68

Alterations in diurnal cortisol rhythm and acoustic startle response in nonhuman primates with adverse rearing. Biol Psychiatry (2005) 1.65

Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biol Psychiatry (2002) 1.65

Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology (2007) 1.63

Hypercortisolemia and depression. Psychosom Med (2005) 1.60

Long-term adaptations in glucocorticoid receptor and mineralocorticoid receptor mRNA and negative feedback on the hypothalamo-pituitary-adrenal axis following neonatal maternal separation. Biol Psychiatry (2004) 1.59

Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation (2003) 1.59

Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation. Neuropsychopharmacology (2006) 1.59

Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry (2005) 1.58

A haplotype map of genomic variations and genome-wide association studies of agronomic traits in foxtail millet (Setaria italica). Nat Genet (2013) 1.58

CREB: a multifaceted regulator of neuronal plasticity and protection. J Neurochem (2010) 1.58

Long-lasting changes in stress-induced corticosterone response and anxiety-like behaviors as a consequence of neonatal maternal separation in Long-Evans rats. Pharmacol Biochem Behav (2002) 1.56

mTOR complex component Rictor interacts with PKCzeta and regulates cancer cell metastasis. Cancer Res (2010) 1.54

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. J Clin Psychiatry (2007) 1.54

High throughput proteome screening for biomarker detection. Mol Cell Proteomics (2005) 1.54

Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression. Biol Psychiatry (2007) 1.51

Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol (2010) 1.51

Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients. Eur J Cancer (2011) 1.51

Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. Cancer Res (2005) 1.51

Stimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells. Mol Vis (2006) 1.50

Social facilitation of wound healing. Psychoneuroendocrinology (2004) 1.49

Optimizing selective cerebral perfusion: deleterious effects of high perfusion pressures. J Thorac Cardiovasc Surg (2008) 1.48

Neurobiology of posttraumatic stress disorder. CNS Spectr (2009) 1.48

Corra: Computational framework and tools for LC-MS discovery and targeted mass spectrometry-based proteomics. BMC Bioinformatics (2008) 1.48

Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J Cereb Blood Flow Metab (2006) 1.48

Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. Neuropsychopharmacology (2005) 1.47

High severity and fatality of human infections with avian influenza A(H7N9) infection in China. Clin Infect Dis (2013) 1.47

Neonatal maternal separation reduces hippocampal mossy fiber density in adult Long Evans rats. Brain Res (2002) 1.47

International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Trials (2011) 1.46

Increased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice. Proc Natl Acad Sci U S A (2011) 1.45

UniPep--a database for human N-linked glycosites: a resource for biomarker discovery. Genome Biol (2006) 1.43

Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol (2010) 1.42

Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale. CMAJ (2005) 1.42

Polymorphisms in CRHR1 and the serotonin transporter loci: gene x gene x environment interactions on depressive symptoms. Am J Med Genet B Neuropsychiatr Genet (2010) 1.42

GRIM-19 inhibits the STAT3 signaling pathway and sensitizes gastric cancer cells to radiation. Gene (2012) 1.42

Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects. Neuropsychopharmacology (2004) 1.41

Prompt upper endoscopy is an appropriate initial management in uninvestigated chinese patients with typical reflux symptoms. Am J Gastroenterol (2010) 1.41

Effect of Childhood Trauma on Adult Depression and Neuroendocrine Function: Sex-Specific Moderation by CRH Receptor 1 Gene. Front Behav Neurosci (2009) 1.41

Defining forces that are associated with shoulder dystocia: the use of a mathematic dynamic computer model. Am J Obstet Gynecol (2003) 1.41

Jugular vein catheterization for repeated blood sampling in the unrestrained conscious rat. Brain Res Brain Res Protoc (2002) 1.40

Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. J Clin Psychiatry (2007) 1.40

Does reduced IGF-1R signaling in Igf1r+/- mice alter aging? PLoS One (2011) 1.39

Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry (2007) 1.38

Model test of anchoring effect on zonal disintegration in deep surrounding rock masses. ScientificWorldJournal (2013) 1.38

Sponge transgenic mouse model reveals important roles for the microRNA-183 (miR-183)/96/182 cluster in postmitotic photoreceptors of the retina. J Biol Chem (2011) 1.38

Neurobiology of early life stress: clinical studies. Semin Clin Neuropsychiatry (2002) 1.38

High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting. PLoS One (2012) 1.36

Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice. PLoS One (2011) 1.36

Neutrophils promote experimental choroidal neovascularization. Mol Vis (2005) 1.35

Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J Immunol (2004) 1.35